Clinical trial Recruiting at 1 site Observational Ages 18 to 60 Women only

Imaging endometriosis with total-body PET-CT in women with suspected disease

Official title: Novel Non-invasive Imaging of Endometriosis Using Total-body PET-CT Programme (PET-Endo)

Run by University of Edinburgh · NCT07523997 · Data updated 2026-11-12

This study tests whether total-body PET-CT with special tracers can help identify endometriosis in women who are likely to have the condition and are planning laparoscopy.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexWomen only
Enrollment30 (estimated)
SponsorUniversity of Edinburgh
Academic / other
Locations1 site (Edinburgh, City Of Edinburgh)
StatusRecruiting
StartedApril 8, 2026
Main results expectedApril 1, 2027
Study endsDecember 31, 2027
Registry record updatedMay 27, 2026
Trial IDNCT07523997 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women with chronic pelvic pain and a clinical/radiologic diagnosis suggesting endometriosis who are scheduled for confirmatory laparoscopy within four months.

Probably not a fit

Patients without endometriosis or with imaging patterns not reflected by disease may not benefit from the imaging approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit up to 30 women with chronic pelvic pain and a clinical or radiologic suspicion of endometriosis who are planning laparoscopy. Participants will undergo two imaging sessions: total-body PET-CT with two different tracers (68Ga-FAPI and 18F-GP1) and PET/MRI for anatomical correlation, along with a baseline assessment and an online acceptability survey. Surgical findings and tissue samples will be compared with imaging results to see how well the scans reflect actual disease. This observational study aims to correlate tracer uptake with pathology and clinical information. Data will be collected on demographics, medical history, prior imaging, and patient-reported experiences.

Why it matters

Potential benefit: If successful, the imaging approach could improve noninvasive detection and mapping of endometriosis.

How similar studies have gone: Prior imaging techniques in endometriosis have limited sensitivity; this approach with novel tracers is exploratory and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic pelvic pain
* Clinical/radiological diagnosis of likely endometriosis and due to undergo confirmatory laparoscopy in the subsequent four months

Exclusion Criteria:

* Inability or unwilling to give informed consent
* Actively trying to conceive, pregnant or breastfeeding
* Post menopausal (no periods for \>12 months and not taking hormonal treatments to prevent periods or bilateral oophorectomy performed)
* Previous hysterectomy
* Confirmed or suspected pelvic malignancy
* Contraindication to MRI (ferromagnetic material in the body, metallic device implantation or claustrophobia)
* Contraindication to buscopan (e.g. glaucoma, unstable cardiac disease, arrythmias, myasthenia, previous hypersensitivity to buscopan)
* Taking part in a CTIMP or interventional non-CTIMP study
* Previous severe pelvic inflammatory disease
* Previous peritonitis

Where it's running

  • Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh
    Edinburgh, City Of Edinburgh, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Lucy HR Whitaker, MD — University of Edinburgh
  • Study coordinator: Lucy HR Whitaker, MD
  • Email: ETMT@ed.ac.uk
  • Phone: 01316518321

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.